Central Nervous System Diseases clinical trials at University of California Health
3 in progress, 1 open to eligible people
A Follow-On Study of Donanemab (LY3002813) With Video Assessments in Participants With Alzheimer's Disease (TRAILBLAZER-EXT)
open to eligible people ages 60-90
The main goals of this study are to further determine whether the study drug donanemab is safe and effective in participants with Alzheimer's disease and to validate video scale assessments.
at UC Irvine
Human Epilepsy Project 2: Resistant Focal Seizures Study
Sorry, in progress, not accepting new patients
The HEP2 study is designed to better understand the challenges of living with focal seizures that do not respond to medication, by following 205 people with medication-resistant focal epilepsy over two years to measure changes in health status, healthcare costs, quality of life, and biomarkers of epilepsy severity and treatment response.
at UCSF
Safety and Efficacy Study of VY-AADC01 for Advanced Parkinson's Disease
Sorry, in progress, not accepting new patients
Safety and efficacy of AADC gene transfer in participants with Parkinson's disease.
at UCSF
Last updated: